How a Leading Antidepressant Became the Center of the Largest Healthcare Fraud Settlement in U.S. History Paxil (paroxetine), an SSRI antidepressant manufactured by GlaxoSmithKline (GSK), was one of the most widely prescribed antidepressants of the 1990s and 2000s. Approved by the FDA for adults suffering from depression, anxiety, and obsessive-compulsive disorder, Paxil generated billions in annual revenue for GSK at its peak. But the drug's commercial success was built, in

A Common Agricultural Chemical with Devastating Neurological Consequences Paraquat dichloride is one of the most widely used herbicides in the world, applied on millions of acres of farmland to control weeds and grasses. It has been commercially available since the 1960s and is sold under various brand names, including Gramoxone (manufactured by Syngenta). While it is banned or restricted in many countries due to its toxicity, paraquat remains legally available and heavily us

When Stopping the Bleed Was Impossible Xarelto (rivaroxaban), jointly marketed by Bayer and Janssen Pharmaceuticals (a Johnson & Johnson subsidiary), was approved by the FDA in 2011 as a next-generation anticoagulant — a blood thinner designed to prevent dangerous clots in patients with atrial fibrillation, deep vein thrombosis, and other conditions. It was marketed as a convenient alternative to warfarin, requiring no routine blood monitoring and offering a once-daily dosing

A "Permanent Solution" That Created Permanent Problems Essure was marketed as a revolutionary breakthrough in contraception — a minimally invasive, non-hormonal, permanent birth control device. Manufactured by Conceptus and later acquired by Bayer, Essure consisted of two small metal coils inserted into the fallopian tubes, where scar tissue would form to create a natural barrier against pregnancy. It was FDA-approved in 2002 and offered as an outpatient alternative to surgic

When the Cure Was Worse Than the Condition In the 1990s, the combination of fenfluramine and phentermine — popularly known as "fen-phen" — became the hottest diet drug in America. Millions of patients seeking weight loss embraced the combination, and by the mid-1990s, an estimated 6 million Americans had taken it. The drug was hailed as a breakthrough, with physicians prescribing it enthusiastically for patients struggling with obesity. But the miracle weight-loss regimen was

A Trusted Heartburn Drug with a Toxic Secret For decades, Zantac (ranitidine) was one of the world's best-selling medications, trusted by millions to treat heartburn, acid reflux, and ulcers. At its peak, it was the first drug in history to reach $1 billion in global sales. But beneath this commercial success lurked a chemistry problem that would eventually pull Zantac from pharmacy shelves worldwide and trigger one of the largest pharmaceutical litigation waves in recent mem

How Deceptive Marketing Fueled a National Crisis In 1996, Purdue Pharma launched OxyContin with a bold and ultimately fraudulent claim: that its time-release formula made the drug less addictive than other opioids. Armed with aggressive marketing campaigns targeting physicians, the company assured the medical community that fewer than 1% of patients would develop addiction. That claim was not only unsupported by evidence — it was a lie that helped ignite the deadliest drug cr

When Pain Relief Became a Death Sentence In the late 1990s, Merck & Co. introduced Vioxx (rofecoxib) as a revolutionary painkiller — a COX-2 inhibitor designed to relieve arthritis pain with fewer gastrointestinal side effects than traditional NSAIDs. Marketed aggressively to millions of patients, Vioxx quickly became one of the best-selling drugs in history, generating over $2.5 billion annually at its peak. But behind the blockbuster sales figures lay a dangerous secret. Th

By Dr. Alberto Augsten, Toxicologist and Psychopharmacologist The 2023 Canadian wildfire season burned morWildfire smoke shrouds a city skyline. Canada's 2023 fire season pushed PM2.5 concentrations to record levels across North America and reshaped the toxicology of urban air.e than 18 million hectares and pushed continent-spanning smoke plumes into the eastern United States, transforming wildfire smoke from a regional summer nuisance into a defining toxicological challenge

By Dr. Alberto Augsten, Toxicologist and Psychopharmacologist South Africa's complex history with lead exposure runs through a century of mining, smelting, industrial production, and ongoing community contamination. From the Kabwe smelter complex in neighboring Zambia (long supplied by South African industry) to active battery recycling operations on the Witwatersrand, the country illustrates how lead toxicology continues to shape African public health well into the twenty-fi

By Dr. Alberto Augsten, Toxicologist and Psychopharmacologist Australia became the global epicenter of a rapid and devastating resurgence of silicosis among workers fabricating engineered stone benchtops. Once thought to be a disease of nineteenth-century miners, accelerated silicosis began appearing in young Australian stonemasons in the mid-2010s, prompting some of the strictest national workplace silica regulations in the world — and an unprecedented 2024 nationwide ban on

Hazmat-suited personnel conduct decontamination work. The Salisbury and Navalny Novichok incidents demonstrated the extreme persistence and lethality of fourth-generation nerve agents. By Dr. Alberto Augsten, Toxicologist and Psychopharmacologist Novichok agents represent the most potent class of organophosphorus nerve agents ever developed and weaponized. Originally synthesized in the Soviet Union under the Foliant program from the 1970s through the 1990s, these so-called fo

Aerial pesticide application over Brazilian farmland. Brazil leads the world in agrochemical consumption, with pronounced occupational and community health consequences. By Dr. Alberto Augsten, Toxicologist and Psychopharmacologist Brazil is the world's largest consumer of agricultural pesticides. The country's vast soy, sugarcane, corn, and cotton industries depend on intensive agrochemical use, and Brazilian regulators have approved hundreds of new pesticide formulations in

By Dr. Alberto Augsten, Toxicologist and Psychopharmacologist Few toxicological catastrophes have shaped modern environmental health policy as profoundly as Minamata. Between 1932 and 1968, the Chisso chemical plant in Kumamoto Prefecture released methylmercury-laden wastewater into Minamata Bay, contaminating the marine food web and poisoning tens of thousands of people who ate local fish and shellfish. The resulting disease — Minamata disease — became the prototype for unde

By Dr. Alberto Augsten, Toxicologist and Psychopharmacologist Germany has become an unlikely epicenter of the European PFAS story. From the discovery of widespread per- and polyfluoroalkyl substance contamination in agricultural soils around Rastatt and Baden-Baden in 2013 to the ongoing detection of PFAS in drinking water near Mannheim, German communities have provided some of the most detailed real-world data on chronic low-dose PFAS exposure in Europe — and German regulato

By Dr. Alberto Augsten, Toxicologist and Psychopharmacologist Carbon monoxide (CO) poisoning remains a stubbornly persistent cause of accidental death and chronic illness in the United Kingdom. Despite decades of public awareness campaigns, mandatory CO alarms in rented dwellings in England, and tighter gas-safety regulation, the UK still records roughly 50 to 60 fatalities and several thousand hospital admissions from non-fire CO exposure each year, with the true incidence o

By Dr. Alberto Augsten, Toxicologist and Psychopharmacologist Hexavalent chromium, or chromium-6, has emerged as one of India's most pressing toxicological challenges. Communities living downstream of industrial activities in regions like Kanpur, Vellore, Odisha, and Jharkhand face chronic exposure through groundwater, irrigation water, and soil. The health consequences of this exposure are only beginning to be fully documented by public health systems. Why Chromium-6 Matters

Terraced rice paddies in southern China, where cadmium-contaminated soils and irrigation water have driven a decades-long food safety challenge. By Dr. Alberto Augsten, Toxicologist and Psychopharmacologist Cadmium contamination of rice and farmland in southern China has emerged as one of the most consequential food-safety stories of the past two decades. Surveys in Hunan, Guangxi, and Guangdong provinces have repeatedly identified cadmium concentrations in rice that exceed b

Petrochemical complexes along the Texas Gulf Coast emit benzene and other carcinogens toward nearby communities. By Dr. Alberto Augsten, Toxicologist and Psychopharmacologist An April 2026 study published by The Texas Tribune confirmed what communities in Houston, Port Arthur, Corpus Christi, and the Texas Gulf Coast petrochemical corridor have been reporting for decades: benzene emissions along the Texas coast are among the highest in the nation. For families — many of them

Urban California communities face chronic exposure to air pollutants like ethylene oxide and acrolein, with elevated cancer risk. By Dr. Alberto Augsten, Toxicologist and Psychopharmacologist In May 2026, California's Office of Environmental Health Hazard Assessment (OEHHA) released new draft cancer risk assessments for two pollutants millions of Californians breathe every day: ethylene oxide and acrolein. The findings are alarming: both chemicals can pose an estimated cancer